CW
TGTX icon

CreativeOne Wealth’s TG Therapeutics TGTX Stock Holding History

CreativeOne Wealth’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,125
Closed -$227K – 808
2023
Q2 		$227K Buy
+9,125
New +$236K 0.01% 740
2022
Q4 		– Sell
-10,275
Closed -$61K – 779
2022
Q3 		$61K Sell
10,275
-529
-5% -$3.47K ﹤0.01% 687
2022
Q2 		$46K Buy
10,804
+329
+3% +$2.05K ﹤0.01% 706
2022
Q1 		$100K Hold
10,475
– – 0.01% 719
2021
Q4 		$199K Buy
10,475
+300
+3% +$7.79K 0.01% 723
2021
Q3 		$339K Hold
10,175
– – 0.02% 520
2021
Q2 		$395K Buy
+10,175
New +$400K 0.02% 450

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

CreativeOne Wealth's TGTX Position: Q3 2023 in Review

CreativeOne Wealth sold out of TG Therapeutics (TGTX) in Q3 2023, closing a stake of 9,125 shares — an estimated $227K sold.

CreativeOne Wealth first reported a position in TGTX in Q2 2021 and held it in 7 quarters. The position peaked at $395K in Q2 2021. 236 funds tracked by Wall St. Rank hold TGTX as of Q3 2023.

  • CreativeOne Wealth reported no remaining TG Therapeutics position as of Q3 2023 after selling out during the quarter.
  • CreativeOne Wealth sold 9,125 TG Therapeutics shares in Q3 2023, an estimated $227K.
  • CreativeOne Wealth first reported a position in TG Therapeutics in Q2 2021 and held it in 7 quarters.
  • CreativeOne Wealth's TG Therapeutics position peaked at $395K in Q2 2021.
  • 236 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2023.

Based on CreativeOne Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.